342300login-checkDiabetes Patients on Dialysis See Better Sugar Control With Artificial Pancreas |
“Adults with type 2 diabetes and end-stage renal disease requiring dialysis benefitted from an artificial pancreas in a small, randomized crossover trial.
Patients using a fully automated closed loop system spent a longer amount of time in target glucose range versus those using standard insulin therapy (52.8% vs 37.7%, respectively, P<0.001), reported Charlotte Boughton, MD, PhD, of University of Cambridge Metabolic Research Laboratories in England, and colleagues.”
Read more, here.
342300login-checkDiabetes Patients on Dialysis See Better Sugar Control With Artificial Pancreas |